Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S37, 2019. DOI: 10.25251/skin.3.supp.37. Disponível em: https://skin.dermsquared.com/skin/article/view/764. Acesso em: 19 apr. 2025.